A Case Series on the Efficacy and Safety of a PD-1 Inhibitor Combined with Antiangiogenic Agents in the Treatment of Recurrent MSI-H Endometrial Cancer.
GLAND SURGERY（2023）
Key words
Endometrial cancer,PD-1,antiangiogenic agent,immunotherapy,case series
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined